We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.22B
AUM Growth
+$121M
Cap. Flow
+$81.9M
Cap. Flow %
2.54%
Top 10 Hldgs %
38.22%
Holding
150
New
21
Increased
61
Reduced
47
Closed
20

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$53.4M
2
ITUB icon
Itaú Unibanco
ITUB
+$45.2M
3
ADBE icon
Adobe
ADBE
+$42.3M
4
CMCSA icon
Comcast
CMCSA
+$42M
5
BIDU icon
Baidu
BIDU
+$38.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.96%
2 Communication Services 17.8%
3 Technology 16.92%
4 Financials 13.78%
5 Healthcare 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMX icon
26
Fomento Económico Mexicano
FMX
$41.7B
$47.8M 1.49%
496,674
-303,466
-38% -$27.7M
GILD icon
27
Gilead Sciences
GILD
$165B
$47.4M 1.47%
515,696
-23,120
-4% -$2.08M
NBIS
28
Nebius Group N.V.
NBIS
$47.7B
$45.1M 1.4%
2,943,555
+116,000
+4% +$1.59M
CMCSA icon
29
Comcast
CMCSA
$90B
$44.7M 1.39%
+1,463,700
New +$42M
UHS icon
30
Universal Health Services
UHS
$10.5B
$44.5M 1.38%
356,590
+38,177
+12% +$4.29M
STZ icon
31
Constellation Brands
STZ
$23.2B
$43M 1.34%
284,890
+37,550
+15% +$5.42M
ATVI
32
DELISTED
Activision Blizzard
ATVI
$42.6M 1.32%
1,259,100
+190,071
+18% +$6.23M
C icon
33
Citigroup
C
$226B
$42.4M 1.32%
1,015,334
-13,025
-1% -$544K
IFF icon
34
International Flavors & Fragrances
IFF
$21.9B
$39.6M 1.23%
348,140
+59,800
+21% +$6.69M
ROK icon
35
Rockwell Automation
ROK
$49B
$37.8M 1.18%
332,720
-3,670
-1% -$372K
BAP icon
36
Credicorp
BAP
$30.7B
$34.6M 1.08%
264,128
+23,430
+10% +$2.58M
WBC
37
DELISTED
WABCO HOLDINGS INC.
WBC
$32.9M 1.02%
307,650
-41,890
-12% -$3.96M
AMZN icon
38
Amazon
AMZN
$2.96T
$31.8M 0.99%
1,072,560
-991,300
-48% -$28.1M
IBN icon
39
ICICI Bank
IBN
$108B
$30.4M 0.94%
4,664,784
-4,872,097
-51% -$28.6M
SLB icon
40
SLB Ltd
SLB
$75B
$28.6M 0.89%
387,179
-4,290
-1% -$302K
AVGO icon
41
Broadcom
AVGO
$2.04T
$26.9M 0.84%
+1,742,400
New +$23.6M
PM icon
42
Philip Morris
PM
$295B
$25.3M 0.79%
258,316
-31,114
-11% -$2.85M
HDB icon
43
HDFC Bank
HDB
$121B
$24.4M 0.76%
1,581,748
+81,480
+5% +$1.16M
ALLE icon
44
Allegion
ALLE
$14.4B
$23.2M 0.72%
364,810
-97,567
-21% -$5.96M
MS icon
45
Morgan Stanley
MS
$340B
$20.9M 0.65%
834,148
-229,350
-22% -$5.85M
TCOM icon
46
Trip.com Group
TCOM
$29.1B
$17.6M 0.55%
398,135
-3,252
-0.8% -$136K
NTES icon
47
NetEase
NTES
$84.7B
$17.6M 0.55%
+612,750
New +$18.4M
RCL icon
48
Royal Caribbean
RCL
$85.6B
$17.3M 0.54%
210,750
-360,100
-63% -$28.1M
PBR icon
49
Petrobras
PBR
$116B
$16.2M 0.5%
+2,781,100
New +$11.2M
SQM icon
50
Sociedad Química y Minera de Chile
SQM
$20.6B
$16.2M 0.5%
+809,594
New +$14M

Similar funds

Axiom Investors's Q1 2016 Portfolio in Review

As of Q1 2016, Axiom Investors held 150 positions worth $3.22B, up 3.9% from $3.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Axiom Investors's Q1 2016 filing shows 21 new, 61 increased, 47 reduced and 20 closed positions. Its largest new stake was CVS Health: 549,054 shares worth $57M. The largest sale was Check Point Software Technologies, an estimated $67.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 23% a quarter earlier, followed by Communication Services and Technology.

  • Axiom Investors's largest Q1 2016 buy was CVS Health: 549,054 shares worth $57M.
  • Axiom Investors added most to Itaú Unibanco in Q1 2016, an estimated $45.2M increase.
  • Axiom Investors's biggest Q1 2016 reduction was Check Point Software Technologies, cutting an estimated $67.5M.
  • Axiom Investors fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $42.2M.
  • Axiom Investors's ten largest holdings make up 38% of its $3.22B portfolio in Q1 2016.
  • Axiom Investors opened 21 new positions and closed 20 in Q1 2016.
  • Axiom Investors's portfolio value rose 3.9% quarter-over-quarter to $3.22B.

Based on Axiom Investors's 13F filing for Q1 2016, filed 12 May 2016.